SUCCESSFUL FERTILITY RESTORATION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

被引:15
|
作者
Gharwan, Helen [1 ]
Neary, Nicola M. [2 ]
Link, Mary [3 ]
Hsieh, Matthew M. [3 ]
Fitzhugh, Courtney D. [3 ]
Sherins, Richard J. [4 ]
Tisdale, John F. [3 ,4 ]
机构
[1] NCI, Med Oncol Branch, Bethesda, MD 20892 USA
[2] St George Hosp, Dept Endocrinol, London, England
[3] NHLBI, Mol & Clin Hematol Branch, Bethesda, MD 20892 USA
[4] Columbia Fertil Associates, Washington, DC USA
关键词
BONE-MARROW-TRANSPLANTATION; IRON OVERLOAD; DISEASE; HYPOGONADISM; PARAMETERS; HYDROXYUREA; RECIPIENTS; RADIATION; THERAPY;
D O I
10.4158/EP13474.CR
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Myeloablative conditioning regimens given prior to hematopoietic stem cell transplantation (HSCT) frequently cause permanent sterility in men. In patients with sickle cell disease (SCD) we use a nonmyeloablative regimen with sirolimus, alemtuzumab, and low-dose total-body irradiation (300 centigrays) with gonadal shielding preceding allogeneic HSCT. We report here the restoration of azoospermia in a patient with SCD after allogeneic HSCT. We discuss the impact of our patient's underlying chronic medical conditions and the therapies he had received (frequent blood transfusions, iron chelating drugs, ribavirin, hydroxyurea, opioids), as well as the impact of the nonmyeloablative conditioning regimen on male gonadal function, and we review the literature on this topic. Methods: We determined the patient's reproductive hormonal values and his semen parameters before, during, and after HSCT and infertility treatment. In addition, we routinely measured his serum laboratory parameters pertinent to SCD and infertility, such as iron and ferritin levels. A karyotype analysis was performed to assess the potential presence of Klinefelter syndrome. Finally, imaging studies of the patient's brain and testes were done to rule out further underlying pathology. Results: A 42-year-old man with SCD, transfusional iron overload, and hepatitis C underwent a nonmyeloablative allogeneic HSCT. One year later he desired to father a child but was found to be azoospermic in the context of hypogonadotropic hypogonadism. Restoration of fertility was attempted with human chorionic gonadotropin (2,000 IU) plus human menopausal gonadotropin (75 IU follicle-stimulating hormone) injected subcutaneously 3 times weekly. Within 6 months of treatment, the patient's serum calculated free testosterone value normalized, and his sperm count and sperm motility improved. After 10 months, he successfully initiated a pregnancy through intercourse. The pregnancy was uncomplicated, and a healthy daughter was delivered naturally at term. Conclusion: Despite exposure to several gonadotoxins, transfusional iron overload and nonmyeloablative conditioning with radiation causing severe testicular atrophy suggesting extensive damage to seminiferous tubules and possibly Leydig cells, gonadotropins were efficacious in restoring our patient's reproductive capability.
引用
收藏
页码:E157 / E161
页数:5
相关论文
共 50 条
  • [21] MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Comak, Elif
    Dogan, Cagla Serpil
    Gokceoglu, Arife Uslu
    Yesilipek, Akif
    Koyun, Mustafa
    Akman, Sema
    PEDIATRIC NEPHROLOGY, 2012, 27 (09) : 1686 - 1686
  • [22] Bronchial Disorders After Allogeneic Hematopoietic Stem Cell Transplantation
    Bergeron, A.
    Godet, C.
    Chevret, S.
    Lorillon, G.
    de Latour, R. Peffault
    Robin, M.
    Ribaud, P.
    Socie, G.
    Tazi, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [23] Diabetes Mellitus after Allogeneic Hematopoietic Stem Cell Transplantation
    Wedrychowicz, Anna
    Ciechanowska, Marta
    Stelmach, Malgorzata
    Starzyk, Jerzy
    HORMONE RESEARCH IN PAEDIATRICS, 2013, 79 (01): : 44 - 50
  • [24] Bullous pemphigoid after allogeneic hematopoietic stem cell transplantation
    Kato, Keisuke
    Koike, Kazutoshi
    Kobayashi, Chie
    Iijima, Shigeruko
    Hashimoto, Takashi
    Tsuchida, Masahiro
    PEDIATRICS INTERNATIONAL, 2015, 57 (03) : 480 - 483
  • [25] Management of dyslipidemia after allogeneic hematopoietic stem cell transplantation
    Yingxue Lu
    Xiaojing Ma
    Jie Pan
    Rongqiang Ma
    Yujie Jiang
    Lipids in Health and Disease, 21
  • [26] Graft failure after allogeneic hematopoietic stem cell transplantation
    Ozdemir, Zehra Narli
    Bozdag, Sinem Civriz
    TRANSFUSION AND APHERESIS SCIENCE, 2018, 57 (02) : 163 - 167
  • [27] ABO antibodies after allogeneic hematopoietic stem cell transplantation
    Stussi, G
    Huggel, K
    Schanz, U
    Halter, J
    Passweg, J
    Gratwohl, A
    Seebach, JD
    BONE MARROW TRANSPLANTATION, 2003, 31 : S114 - S114
  • [28] Immune Reconstitutional after Allogeneic Hematopoietic Stem Cell Transplantation
    Ogonek, Justyna
    Juric, Mateja Kralj
    Ghimire, Sakhila
    Varanasi, Pavankumar Reddy
    Holler, Ernst
    Greinix, Hildegard
    Weissinger, Eva
    FRONTIERS IN IMMUNOLOGY, 2016, 7
  • [29] Visceral leishmaniasis after allogeneic hematopoietic stem cell transplantation
    Agteresch, H. J.
    Veer, M. B. van 't
    Cornelissen, J. J.
    Sluiters, J. F.
    BONE MARROW TRANSPLANTATION, 2007, 40 (04) : 391 - 393
  • [30] Management of dyslipidemia after allogeneic hematopoietic stem cell transplantation
    Lu, Yingxue
    Ma, Xiaojing
    Pan, Jie
    Ma, Rongqiang
    Jiang, Yujie
    LIPIDS IN HEALTH AND DISEASE, 2022, 21 (01)